FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/17/2023
Back to search
Official data from USPTO
PLEXPLUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PLEXPLUS
ST13
US500000079337468Class
1, 5, 10, 42, 44
Filing
79337468
Registration
7057884
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
09/17/2023
Trademark type
Word
Nice classes
1, 5, 10, 42, 44
Filing date
09/27/2021
Registration date
05/23/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/23/2023
Last transaction
05/23/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
82
Owner location
AU
Examiner
HESIK, APRIL
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SpeeDx Pty Ltd
Representatives
Joi A. White Carr & Ferrell LLP
Technical classification
Nice Classes
Class 1Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industry and science; chemical preparations for use in photography; chemicals for use in agriculturehorticulture and forestry except fungicidesherbicidesinsecticides and parasiticides; reagents and reactants in this class for scientific and research usemedical research usenonmedical use; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acid for other than medical and veterinary purposes; acids namely inorganic acids for industrial purposes; DNA polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring
Class 5
Pharmaceutical and veterinary preparations and substances consisting of catalytic DNA molecules and associated detection reagents for the diagnosis of diseasesfor detection and identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppression and immune disordersfor genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsfor analysis of response to therapy; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing preparations for medical use; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsanalysis of response to therapy; chemical preparations containing enzymes for pharmaceuticalveterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsanalysis of response to therapy; enzymes for pharmaceuticalveterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsanalysis of response to therapy; medical kits containing medical and/or pharmaceutical preparations and associated detection reagents for the diagnosis of diseasesfor detection and identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppression and immune disordersfor genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsfor analysis of response to therapy; clinical diagnostic preparations for medical or veterinary use; biological chemical diagnostic test kits comprised of reagents and assays for medical laboratory use in analysis that test for the presence of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppressionimmune disorders
Class 10
Surgical apparatus and instruments; medical and veterinary apparatus and instruments being diagnostic testing apparatus and instruments for the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsanalysis of response to therapy; diagnostic testing apparatus and instruments for medical purposes; diagnostic testing kits consisting primarily of diagnostic testing apparatus and instruments for the purpose of detecting antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsanalysis of response to therapy; point of care medical devices being diagnostic testing apparatus for the purpose of detecting antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsanalysis of response to therapy; medical screening kits comprised of medical screening and testing apparatus for the diagnosis of diseasedetection and identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and immune disorders for genotypinganalysis of polymorphismsdetection of acquired and inherited genetic mutationsdetection and analysis of epigenetic alterationsanalysis of response to therapy; biological chemical test kits for medical laboratory use in analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppressionimmune disorders
Class 42
Scientific and technological services and research and design relating theretoDNA analysis services for scientific research purposesscientific research consulting in the field of genetics; scientific research in the field of genetics; genetic engineering services for scientific purposes; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; laboratory analysis in the field of chemistry; development of medical diagnostic apparatus; design of medical diagnostic apparatus; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biologicalbacteriologicalchemicalbiochemicaldnarnaproteinpolynucleic acid and molecular analysis and evaluation services; dna and rna and polynucleic acid and protein sequencinganalysis and evaluation services; genome sequencing services and the analysis and evaluation of data resulting therefrom; provision of reports relating to scientific and medical experimentsthe results of scientific and medical experiments and teststhe analysis and evaluation of scientific and medical datadata generated by scientific and medical experiments and tests; scientific and medical research and development services in the field of the diagnosis of diseasedetection and identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsanalysis of response to therapy; custom design and development of biochemical assays
Class 44
Medical services; human healthcare services; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services relating to dnagenetics and genetic testing; medical diagnostic services in the nature of medical testing and medical analysis; providing collected and analysed medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes; medical diagnostic imaging and molecular medicine; molecular medical diagnostics testing
Publications
History of USPTO decisions and trademark events.
38 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/28/2023
FIMP
FINAL DISPOSITION PROCESSED
08/28/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/23/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/23/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
05/23/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/07/2023
PUBO
PUBLISHED FOR OPPOSITION
03/07/2023
GPNX
NOTIFICATION PROCESSED BY IB
03/06/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/15/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/15/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/27/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
01/27/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/27/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
01/27/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/27/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
01/19/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
01/17/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/30/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/29/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/28/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/28/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/12/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/12/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/12/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/12/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/12/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/12/2022
RFNT
REFUSAL PROCESSED BY IB
07/20/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/29/2022
RFRR
REFUSAL PROCESSED BY MPU
06/29/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/29/2022
CNRT
NON-FINAL ACTION WRITTEN
06/28/2022
DOCK
ASSIGNED TO EXAMINER
06/28/2022
MAFR
APPLICATION FILING RECEIPT MAILED
04/12/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/08/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/07/2022
Continuous trademark protection
Get notified about every new filing that threatens PLEXPLUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.